| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/24/2008 | CN101269185A Method for preparing traditional Chinese medicine for treating heart-spleen deficiency type depressive psychosis |
| 09/24/2008 | CN101269181A Phragmites communis trin kuh-seng soup |
| 09/24/2008 | CN101269179A Traditional Chinese medicine preparation for treating senile dementia and preparation method thereof |
| 09/24/2008 | CN101269174A Pharmaceutical composition for improving memory disturbance senile dementia and preparation method thereof |
| 09/24/2008 | CN101269172A Medicament composition for treating hereditary ataxia and preparation method thereof |
| 09/24/2008 | CN101269160A Chinese medicinal composition for treating trigeminal neuralgia |
| 09/24/2008 | CN101269153A Sobering-up composition and preparation method thereof |
| 09/24/2008 | CN101269149A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269148A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269147A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269146A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269133A Application of Chinese medicinal composition in preparing medicament for treating facial spasm |
| 09/24/2008 | CN101269128A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269127A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269122A Suction medicament for treating trigeminal neuralgia and preparation method thereof |
| 09/24/2008 | CN101269112A Traditional Chinese medicine preparation for qi-benefitting, blood-nourishing, wind-expelling and vein-relaxing and preparation method thereof |
| 09/24/2008 | CN101269105A Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269104A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269103A Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269102A Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269101A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 09/24/2008 | CN101269099A Prescription for extending nerve and joining nerve |
| 09/24/2008 | CN101269096A Chinese medicine valid target for treating apoplexy disease |
| 09/24/2008 | CN101269094A Fruit and/or vegetable derived composition |
| 09/24/2008 | CN101269080A Application of dexamethasone and its combination in preparing motion sickness resistant medicament |
| 09/24/2008 | CN101269057A Use of succinic acid as metal disease resistant medicament synergistic agent |
| 09/24/2008 | CN101269035A Nicergoline sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269024A Aktilin sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269014A Orally disintegrating tablet of risperidone and preparation method thereof |
| 09/24/2008 | CN100420739C Nestin-expressing hair follicle stem cells |
| 09/24/2008 | CN100420689C Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant |
| 09/24/2008 | CN100420682C Separating preparation process of salvianolic acid B |
| 09/24/2008 | CN100420483C Sigma ligands for neuronal regeneration and functional recovery |
| 09/24/2008 | CN100420482C Method for short-term and long-term drug dosimetry |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427655 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 09/23/2008 | US7427639 β2-adrenergic receptor agonists |
| 09/23/2008 | US7427638 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/23/2008 | US7427631 especially as inhibitors of MMP12 |
| 09/23/2008 | US7427628 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents |
| 09/23/2008 | US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
| 09/23/2008 | US7427621 neurodegenerative diseases: Alzheimer's disease; amyloid plague |
| 09/23/2008 | US7427617 e.g. 2-[1-(2-Fluorobenzyl)-1H-indazol-3-yl]-5-(3-oxa-9-azabicyclo[3.3.1]non-9-yl)-4pyrimidinylamine; soluble guanylate cyclase stimulant; neurodegenerative diseases, cognition activator; Alhzeimer's, Parkinson's disease, Pick's syndrome, multiple sclerosis, HIV dementia, schizophrenia |
| 09/23/2008 | US7427615 3-substituted-4-pyrimidone derivatives |
| 09/23/2008 | US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 09/23/2008 | US7427598 Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory |
| 09/23/2008 | US7427591 Suppression of immune response via inhibition of cathepsin S |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427485 Method for classification of anti-psychotic drugs |
| 09/23/2008 | US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 09/23/2008 | CA2626142A1 Stabilised aqueous solutions of ergoline compounds |
| 09/23/2008 | CA2450093C Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/23/2008 | CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient |
| 09/23/2008 | CA2416169C Compositions containing therapeutically active components having enhanced solubility |
| 09/23/2008 | CA2395541C New substituted piperidines, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/23/2008 | CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 09/23/2008 | CA2375679C Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 09/23/2008 | CA2371393C Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 09/23/2008 | CA2336833C Remedy with antidepressant effects |
| 09/23/2008 | CA2266479C Vitamin d analogues |
| 09/23/2008 | CA2163256C Adenoviral vectors of animal origin and use thereof in gene therapy |
| 09/18/2008 | WO2008113030A2 Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
| 09/18/2008 | WO2008113006A1 Methods of using quinolinone compounds in treating sodium channel-mediated diseases or conditions |
| 09/18/2008 | WO2008112900A1 Dibenzo[b,f][1,4]oxazapine compounds |
| 09/18/2008 | WO2008112734A1 Heterocyclic-carbonyl-diazabicycloalkanes as modulators of the neuronal nicotinic acetylcholine alpha 4 beta 2, subtype receptor for the treatment of cns related disorders |
| 09/18/2008 | WO2008112674A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 09/18/2008 | WO2008112647A2 Nitroxide radical as a treatment for neurodegeneration |
| 09/18/2008 | WO2008112646A1 Aminopyridines useful as inhibitors of protein kinases |
| 09/18/2008 | WO2008112642A1 Aminopyrimidines useful as inhibitors of protein kinases |
| 09/18/2008 | WO2008112641A2 Methods and compositions for treating thalamocortical dysrhythmia |
| 09/18/2008 | WO2008112562A1 Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia |
| 09/18/2008 | WO2008112440A1 Piperazine and piperidine mglur5 potentiators |
| 09/18/2008 | WO2008112319A2 Methods of treating parkinson's disease using halogenated volatile compounds |
| 09/18/2008 | WO2008112238A1 2, 8-dimethyl-5- [2- (6-methylpyridin-3-yl) -ethyl] -2,3,4, 5-tetrahydro- ih- pyrido [4, 3 -b] indole dihydrochloride (dimebon) for the treatment of chronic pain |
| 09/18/2008 | WO2008111916A1 Glycosphingolipid-aided intracellular delivery of cargo molecules |
| 09/18/2008 | WO2008111871A1 Peroral memantine-based medicinal preparation and a method for the production thereof |
| 09/18/2008 | WO2008111767A1 Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for parkinson's disease prevention or treatment |
| 09/18/2008 | WO2008111674A1 Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa |
| 09/18/2008 | WO2008111669A1 Novel prophylactic and/or therapeutic agent for diabetic neuropathy |
| 09/18/2008 | WO2008111668A1 Novel prophylactic and/or therapeutic agent for neurogenic pain |
| 09/18/2008 | WO2008111590A2 Ampa and nmda receptor antagonists for neurodegenerative diseases |
| 09/18/2008 | WO2008111520A1 Gene related to life extension and use thereof |
| 09/18/2008 | WO2008111450A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/18/2008 | WO2008111063A2 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions |
| 09/18/2008 | WO2008110566A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/18/2008 | WO2008110523A1 Imidazo [1,5-a] pyridine derivatives as inhibitors of glutaminyl cyclase |
| 09/18/2008 | WO2008110508A1 Pyrrolo-pyridine derivatives for the treatment of disorders associated with inappropriate ikk1 activity |
| 09/18/2008 | WO2008110339A2 Polymorphs of rivastigmine hydrogentartrate |
| 09/18/2008 | WO2008110034A1 3-hydroxy fatty acid and its derivatives for improving of learning and/or memory of subjects |
| 09/18/2008 | WO2008110008A1 Amide derivatives as calcium channel blockers |
| 09/18/2008 | WO2008090286A3 Derivatives of imidazo, pyrimido and diazepine pyrimidine-dione, and use thereof as a drug |
| 09/18/2008 | WO2008088900A9 Polymorphic forms of rimonabant base and processes for preparation thereof |
| 09/18/2008 | WO2008087461A3 Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis |
| 09/18/2008 | WO2008087419A3 Animal model for adhd |
| 09/18/2008 | WO2008087323A8 Galenic form for the transmucosal delivery of paracetamol |
| 09/18/2008 | WO2008081041A3 Amorphous and crystalline forms of rivastigmine hydrogentartrate |
| 09/18/2008 | WO2008074813A3 Optiogenin for the treatment of neural diseases |
| 09/18/2008 | WO2008063232B1 Substituted pyrazolopyrimidines |
| 09/18/2008 | WO2008062453A3 Composition containing nicotine base aromatic oils and alkyl salicylate for the delivery of nicotine base in vapour form |